MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

about

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

Item

http://www.wikidata.org/entity/Q47429093

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

@en

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

@nl

type

Item

label

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

@en

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

@nl

prefLabel

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

@en

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

@nl

P1476

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.

@en

P2093

Andrew Wotherspoon

http://www.w3.org/2001/XMLSchema#string

Blanka Hezelova

http://www.w3.org/2001/XMLSchema#string

Carlo M Croce

http://www.w3.org/2001/XMLSchema#string

David Cunningham

http://www.w3.org/2001/XMLSchema#string

Else Bosma

http://www.w3.org/2001/XMLSchema#string

Georgios Vlachogiannis

http://www.w3.org/2001/XMLSchema#string

Javier Fernández Mateos

http://www.w3.org/2001/XMLSchema#string

Jens C Hahne

http://www.w3.org/2001/XMLSchema#string

Khurum Khan

http://www.w3.org/2001/XMLSchema#string

Maria Antonietta Bali

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

Aurora Kinase Inhibitors: Current Status and Outlook

Maximizing the Therapeutic Potential of HSP90 Inhibitors

The role of microRNAs in human liver cancers

Cholangiocarcinoma

Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes

Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma

NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis

Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

P304

1066-1079.e5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2017.10.043

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

154

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29113809

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

5863695

http://www.w3.org/2001/XMLSchema#string